NCCN Chemotherapy Order Templates (NCCN Templates) Reviewer Acknowledgement

The NCCN Templates® reviewers play a critical role in the development and maintenance of the NCCN Templates. NCCN Templates reviewers consist of physicians, pharmacists, and nurses from NCCN Member Institutions. They were selected based on their clinical expertise with regard to systemic therapies as well as disease-specific subspecialty areas. NCCN Template content is reviewed annually based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), the NCCN Drugs & Biologics Compendium (NCCN Compendium®), published drug information and research, and clinical experience. NCCN would like to recognize and thank the following volunteer reviewers for contributing their time and expertise:

Acute Lymphoblastic Leukemia

  • Mark Litzow, MD
    Mayo Clinic Cancer Center

  • Ila M. Saunders, BCOP, PharmD
    UC San Diego Moores Cancer Center

  • Bijal Shah, MD
    Moffitt Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Acute Myeloid Leukemia

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Alice S. Mims, MS, MD
    The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Anal Carcinoma

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Stacey A. Cohen, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Kristin Leonardi-Warren, CNS, ND, RN
    University of Colorado Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

B-Cell Lymphomas

  • Jeremy S. Abramson, MD, MMSc
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Julio C. Chavez, MD
    Moffitt Cancer Center

  • Martina Fraga, PharmD
    University of Michigan Rogel Cancer Center

  • Aaron M. Goodman, MD
    UC San Diego Moores Cancer Center

  • Thomas M. Habermann, MD
    Mayo Clinic Cancer Center

  • Francisco J. Hernandez-Ilizaliturri, MD
    Roswell Park Comprehensive Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Ann S. LaCasce, MD, MMSc
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Kristen B. McCullough, PharmD
    Mayo Clinic Cancer Center

  • Ariela Noy, MD
    Memorial Sloan Kettering Cancer Center

  • Samantha Price, PharmD, BCOP
    Moffitt Cancer Center

  • Ila M. Saunders, BCOP, PharmD
    UC San Diego Moores Cancer Center

  • Stephen D. Smith, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Michael Styler, MD
    Fox Chase Cancer Center

  • Katie Tobon, PharmD, BCOP
    Moffitt Cancer Center

Bladder Cancer

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Arlene O. Siefker-Radtke, MD
    The University of Texas MD Anderson Cancer Center

  • Philippe E. Spiess, MD, MS
    Moffitt Cancer Center

Breast Cancer

  • Anthony D. Elias, MD
    University of Colorado Cancer Center

  • Kristin Leonardi-Warren, CNS, ND, RN
    University of Colorado Cancer Center

  • Karen Lisa Smith, MD, MPH
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • John H. Ward, MD
    Huntsman Cancer Institute at the University of Utah

  • Robert Wesolowski, MD
    The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Central Nervous System Cancers

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Peter Forsyth, MD
    Moffitt Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Seema Nagpal, MD
    Stanford Cancer Institute

  • Katherine B. Peters, FAAN, PhD, MD
    Duke Cancer Institute

Cervical Cancer

  • Nadeem R. Abu-Rustum, MD
    Memorial Sloan Kettering Cancer Center

  • Marta Ann Crispens, MD
    Vanderbilt-Ingram Cancer Center

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

  • Scott Huntington, MD, MPH, MSHP
    Yale Cancer Center/Smilow Cancer Hospital

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

Colon Cancer

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Stacey A. Cohen, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Esophageal and Esophagogastric Junction Cancers

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Michael Gibson, PhD, MD, FACP
    Vanderbilt-Ingram Cancer Center

  • Samuel J. Klempner, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Haeseong Park, MD, MPH
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Gastric Cancer

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Michael Gibson, PhD, MD, FACP
    Vanderbilt-Ingram Cancer Center

  • Samuel J. Klempner, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Haeseong Park, MD, MPH
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Gastrointestinal Stromal Tumors (GIST)

  • Kristen N. Ganjoo, MD
    Stanford Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

Gestational Trophoblastic Neoplasia

  • Christina S. Chu, MD
    Fox Chase Cancer Center

  • Elisabeth J. Diver, MD
    Stanford Cancer Institute

  • Robert L. Giuntoli II, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Jayanthi Lea, MD
    UT Southwestern Simmons Comprehensive Cancer Center

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • David G. Mutch, MD
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Christa I. Nagel, MD
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • R. Kevin Reynolds, MD
    University of Michigan Rogel Cancer Center

  • Edward Tanner, MD
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Hairy Cell Leukemia

  • Julio C. Chavez, MD
    Moffitt Cancer Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Samantha Price, PharmD, BCOP
    Moffitt Cancer Center

Head and Neck Cancers

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Ashish Chintakuntlawar, MD
    Mayo Clinic Cancer Center

  • Kathleen Kerrigan, DO
    Huntsman Cancer Institute at the University of Utah

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • John R. Weis, MD
    Huntsman Cancer Institute at the University of Utah

  • Robert Wesolowski, MD
    The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

  • Francis P. Worden, MD
    University of Michigan Rogel Cancer Center

Hepatobiliary Cancers

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Renuka Iyer, MD
    Roswell Park Comprehensive Cancer Center

  • Robin K. Kelley, MD
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Christopher W. Sherrow, PharmD, BCOP
    Roswell Park Comprehensive Cancer Center

  • Robert Wesolowski, MD
    The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute

Hodgkin Lymphoma

  • Leo I. Gordon, MD
    Robert H. Lurie Comprehensive Cancer Center of Northwestern University

  • Scott Huntington, MD, MPH, MSHP
    Yale Cancer Center/Smilow Cancer Hospital

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

Kaposi Sarcoma

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Chia-Ching J. Wang, MD
    UCSF Helen Diller Family Comprehensive Cancer Center

Kidney Cancer

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Prateek Mendiratta, MD
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • M. Dror Michaelson, PhD, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Malignant Peritoneal Mesothelioma

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Tawee Tanvetyanon, MD
    Moffitt Cancer Center

Malignant Pleural Mesothelioma

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Sandip P. Patel, MD
    UC San Diego Moores Cancer Center

Melanoma: Cutaneous

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Anthony J. Olszanski, MD, RPh
    Fox Chase Cancer Center

  • John A. Thompson, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Melanoma: Uveal

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Anthony J. Olszanski, MD, RPh
    Fox Chase Cancer Center

  • John A. Thompson, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Multiple Myeloma

  • Natalie S. Callander, MD
    University of Wisconsin Carbone Cancer Center

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Lindsay M. Hladnik, PharmD, BCOP
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Leona A. Holmberg, PhD, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Yubin Kang, MD
    Duke Cancer Institute

  • Shaji K. Kumar, MD
    Mayo Clinic Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Ila M. Saunders, BCOP, PharmD
    UC San Diego Moores Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

  • Katie Tobon, PharmD, BCOP
    Moffitt Cancer Center

Myelodysplastic Syndromes

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genes

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

  • Elizabeth Hexner, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Lindsay M. Hladnik, PharmD, BCOP
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Sanjay R. Mohan, MD, MSCI
    Vanderbilt-Ingram Cancer Center

  • James Thompson, MD, MS
    Roswell Park Comprehensive Cancer Center

Myeloproliferative Neoplasms

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

  • Aaron T. Gerds, MD, MS
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Nikolai Podoltsev, PhD, MD
    Yale Cancer Center/Smilow Cancer Hospital

  • Lindsay Rein, MD
    Duke Cancer Institute

  • Ila M. Saunders, BCOP, PharmD
    UC San Diego Moores Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

Neuroendocrine and Adrenal Tumors

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Heidi D. Finnes, PharmD, BCOP
    Mayo Clinic Cancer Center

  • Daniel Halperin, MD
    The University of Texas MD Anderson Cancer Center

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

  • Kristin Leonardi-Warren, CNS, ND, RN
    University of Colorado Cancer Center

  • Christopher H. Lieu, MD
    University of Colorado Cancer Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Jonathan R. Strosberg, MD
    Moffitt Cancer Center

  • Nataliya Uboha, PhD, MD
    University of Wisconsin Carbone Cancer Center

Non-Small Cell Lung Cancer

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Sandip P. Patel, MD
    UC San Diego Moores Cancer Center

  • Aditi P. Singh, MD
    Abramson Cancer Center at the University of Pennsylvania

Occult Primary

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Keith D. Eaton, PhD, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Marvaretta M. Stevenson, MD
    Duke Cancer Institute

Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Lainie Martin, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Theresa L. Werner, MD
    Huntsman Cancer Institute at the University of Utah

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Pancreatic Adenocarcinoma

  • Elena Chiorean, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

Primary Cutaneous Lymphomas

  • Stefan K. Barta, MS, MRCP, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Martina Fraga, PharmD
    University of Michigan Rogel Cancer Center

  • Gaurav Goyal, MD
    O'Neal Comprehensive Cancer Center at UAB

  • Bradley M. Haverkos, MD, MPH, MS
    University of Colorado Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Deepa Jagadeesh, MD, MPH
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Allison V. Jones, MD, FAAD
    St. Jude Children's Research Hospital/The University of Tennessee Health Science Center

  • Kaddie M. Lopez, MSN, RN, OCN, NE-BC
    City of Hope National Medical Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Neha Mehta-Shah, MD, MSCI
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

  • Elise A. Olsen, MD
    Duke Cancer Institute

  • Sima Rozati, MD, PhD
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • Ila M. Saunders, BCOP, PharmD
    UC San Diego Moores Cancer Center

  • Katie Tobon, PharmD, BCOP
    Moffitt Cancer Center

  • Jasmine Zain, MD
    City of Hope National Medical Center

Prostate Cancer

  • Andrew J. Armstrong, ScM, MD
    Duke Cancer Institute

  • Allison Balko, PharmD, BCOP
    Vanderbilt-Ingram Cancer Center

Rectal Cancer

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Alan Chin, PharmD, BCOP
    UCSF Helen Diller Family Comprehensive Cancer Center

  • Stacey A. Cohen, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Small Bowel Adenocarcinoma

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Courtney C. Cavalieri, PharmD, BCOP
    Huntsman Cancer Institute at the University of Utah

  • Rawmina Keshavarzi, PharmD, BCOP
    Stanford Cancer Institute

  • Michael Overman, MD
    The University of Texas MD Anderson Cancer Center

  • Eve M. Segal, PharmD, BCOP
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

  • Audrea H. Szabatura, PharmD, BCOP
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Lindsey Zinck, MSN, RN, OCN
    Abramson Cancer Center at the University of Pennsylvania

Small Cell Lung Cancer

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Rafael Santana-Davila, MD
    Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Soft Tissue Sarcoma

  • Edwin Choy, PhD, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

  • Kristen N. Ganjoo, MD
    Stanford Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

Systemic Light Chain Amyloidosis

  • Martina Fraga, PharmD
    University of Michigan Rogel Cancer Center

  • Carol Ann Huff, MD
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • Yubin Kang, MD
    Duke Cancer Institute

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Michael Styler, MD
    Fox Chase Cancer Center

Systemic Mastocytosis

  • Aaron T. Gerds, MD, MS
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

T-Cell Lymphomas

  • Stefan K. Barta, MS, MRCP, MD
    Abramson Cancer Center at the University of Pennsylvania

  • Gaurav Goyal, MD
    O'Neal Comprehensive Cancer Center at UAB

  • Bradley M. Haverkos, MD, MPH, MS
    University of Colorado Cancer Center

  • Mitchell E. Hughes, PharmD, BCOP
    Abramson Cancer Center at the University of Pennsylvania

  • Scott Huntington, MD, MPH, MSHP
    Yale Cancer Center/Smilow Cancer Hospital

  • Deepa Jagadeesh, MD, MPH
    Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

  • Ashley M. Kenkel, PharmD, BCOP
    Fred & Pamela Buffett Cancer Center

  • Deborah McCue, PharmD, BCOP
    The University of Texas MD Anderson Cancer Center

  • Ila M. Saunders, BCOP, PharmD
    UC San Diego Moores Cancer Center

  • Jasmine Zain, MD
    City of Hope National Medical Center

Testicular Cancer

  • Joel Picus, MD
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Thymomas and Thymic Carcinomas

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Sandip P. Patel, MD
    UC San Diego Moores Cancer Center

Thyroid Carcinoma

  • Sally Barbour, FHOPA, BCOP, PharmD, CPP
    Duke Cancer Institute

  • Kristin Leonardi-Warren, CNS, ND, RN
    University of Colorado Cancer Center

  • Daniel Melzer, PharmD, BCOP
    Moffitt Cancer Center

  • Eric J. Sherman, MD
    Memorial Sloan Kettering Cancer Center

  • Lori J. Wirth, MD
    Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center

Uterine Neoplasms

  • Marta Ann Crispens, MD
    Vanderbilt-Ingram Cancer Center

Vulvar Cancer

  • Nadeem R. Abu-Rustum, MD
    Memorial Sloan Kettering Cancer Center

  • Marta Ann Crispens, MD
    Vanderbilt-Ingram Cancer Center

Waldenström Macroglobulinemia / Lymphoplasmacytic Lymphoma

  • Carol Ann Huff, MD
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

  • Yubin Kang, MD
    Duke Cancer Institute

3025 Chemical Road, Suite 100, Plymouth Meeting, PA 19462
Phone: 215-690-0300
Fax: 215-690-0280
Copyright © 2022 National Comprehensive Cancer Network, All Rights Reserved.

No portion of this Site or any NCCN Content may be copied, transferred, reproduced, modified, or otherwise used for any purpose without NCCN’s express written permission.
See Legal Notices Section for additional notices and terms governing your use of this Site.